NM_004229.4:c.4358G>C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004229.4(MED14):​c.4358G>C​(p.Arg1453Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1453H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)

Consequence

MED14
NM_004229.4 missense

Scores

1
6
9

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.75

Publications

3 publications found
Variant links:
Genes affected
MED14 (HGNC:2370): (mediator complex subunit 14) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. This protein contains a bipartite nuclear localization signal. This gene is known to escape chromosome X-inactivation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18327281).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004229.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED14
NM_004229.4
MANE Select
c.4358G>Cp.Arg1453Pro
missense
Exon 31 of 31NP_004220.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED14
ENST00000324817.6
TSL:1 MANE Select
c.4358G>Cp.Arg1453Pro
missense
Exon 31 of 31ENSP00000323720.1O60244
MED14
ENST00000918215.1
c.4538G>Cp.Arg1513Pro
missense
Exon 33 of 33ENSP00000588274.1
MED14
ENST00000883181.1
c.4451G>Cp.Arg1484Pro
missense
Exon 32 of 32ENSP00000553240.1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
28
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.060
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.084
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.0063
T
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L
PhyloP100
3.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.24
Sift
Uncertain
0.010
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.61
P
Vest4
0.40
MutPred
0.33
Gain of glycosylation at R1453 (P = 0.0033)
MVP
0.51
MPC
2.0
ClinPred
0.74
D
GERP RS
4.1
Varity_R
0.49
gMVP
0.55
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756934224; hg19: chrX-40511065; API